{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:51:01Z","timestamp":1788483061080,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The practice of self-medication is common but not without risk, especially for vulnerable populations such as the pediatric population. Community pharmacists have an important role of vigilance in dispensing drugs available without a medical prescription, with the possibility of carrying out a Pharmaceutical Intervention (PI) if necessary. The aim of our study was to characterize the Pediatric Pharmaceutical Interventions (PPIs) in self-medication carried out during a spontaneous request for a drug at the community pharmacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a descriptive study in 139 pharmacies in the Auvergne-Rh\u00f4ne-Alpes region (France). Data were collected from students under the supervision of internship masters in the pharmacy, using the validated GIPAMED (GrId for PhArmaceutical Self-MEDication interventions) notification grid, the first week of each month, from February to May for five years (2017 to 2021). Collected data were entered on a secure university platform.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 3,552 PIs collected, 8,3% (n\u2009=\u2009286) were PPIs. Of these PPIs, 35% (n\u2009=\u2009100) was generated by requests for optional prescription drugs contraindicated by the pathophysiological condition, 28.3% for drugs requiring a prescription and 20.6% for over the counter drugs not indicated by the symptomatology. Finally, 10% of requests required a referral for a medical consultation. Four Anatomical Therapeutic Chemical (ATC) classes accounted for more than 90% of the requests: respiratory system (39.5%), alimentary tract and metabolism (19.2%), nervous system (11.5%), and musculoskeletal system (10.8%). The most common drugs generating PPIs were: ibuprofen, oxomemazine and combination camphor\/essential oils, mainly due to age-related or weight-related contraindication. Paracetamol also generated PPIs frequently, mainly due to problems with drug compliance and more precise infra-therapeutic doses. When these PPIs were dispensed, the pharmacist\u2019s proposed solutions were accepted in 94.8% (n\u2009=\u2009271) of the cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The community pharmacist has an important role in providing information about medicines and their correct use to patients. Our research shows that this attention benefits vulnerable populations, such as children, even for drugs that are widely used (e.g. paracetamol and non-steroidal anti-inflammatory drugs) or active substances for which there are age-related or weight-related contraindications (e.g. antitussives, camphor combinations).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-023-02180-9","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T09:02:28Z","timestamp":1699261348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pediatric pharmaceutical interventions in self-medication: a descriptive study in community pharmacies"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-5045","authenticated-orcid":false,"given":"Sabrina","family":"Bedhomme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3384-0335","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Vaillant-Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vorilhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Lafarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Pereton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Prunet-Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Vennat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Savanovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"2180_CR1","doi-asserted-by":"crossref","first-page":"204209862211275","DOI":"10.1177\/20420986221127501","volume":"13","author":"D Baracaldo-Santamar\u00eda","year":"2022","unstructured":"Baracaldo-Santamar\u00eda D, Trujillo-Moreno MJ, P\u00e9rez-Acosta AM, Feliciano-Alfonso JE, Calderon-Ospina CA, Soler F. Definition of self-medication: a scoping review. Ther Adv Drug Saf 5 oct. 2022;13:20420986221127500.","journal-title":"Ther Adv Drug Saf 5 oct"},{"key":"2180_CR2","unstructured":"NERES. 16\u00e8me barom\u00e8tre Afipa du selfcare 2017 et 4\u00e8me observatoire europ\u00e9en sur l\u2019autom\u00e9dication 2016. https:\/\/neres.fr\/wp-content\/uploads\/2018\/02\/16eme-barometre-afipa-du-selfcare-2017-et-4eme-observatoire-europeen-automedication-2016.pdf. Accessed 16 May 2023."},{"key":"2180_CR3","unstructured":"AFIPA. Barom\u00e8tre Afipa 2019 des produits de SELFCARE Synth\u00e8se des r\u00e9sultats. 2020. https:\/\/neres.fr\/wp-content\/uploads\/2020\/02\/2020-02-03-Barom%C3%A8tre-Afipa-du-Selfcare-2019-VERSION-FINALE.pdf. Accessed 23 Feb 2023."},{"issue":"5","key":"2180_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/0253-7613.190728","volume":"48","author":"A Panda","year":"2016","unstructured":"Panda A, Pradhan S, Mohapatra G, Mohapatra J. Drug-related problems associated with self-medication and medication guided by prescription: a pharmacy-based survey. Indian J Pharmacol. 2016;48(5):515\u201321.","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"2180_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pharma.2012.05.002","volume":"70","author":"B Charpiat","year":"2012","unstructured":"Charpiat B, Henry A, Leboucher G, Tod M, Allenet B. Overdosed prescription of Paracetamol (acetaminophen) in a teaching hospital. Ann Pharm Fr. 2012;70(4):213\u20138.","journal-title":"Ann Pharm Fr"},{"issue":"6","key":"2180_CR6","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"AM Larson","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute Liver Failure: results of a United States multicenter, prospective study. Hepatol Baltim Md. 2005;42(6):1364\u201372.","journal-title":"Hepatol Baltim Md"},{"issue":"11","key":"2180_CR7","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/j.1572-0241.2007.01388.x","volume":"102","author":"WA Bower","year":"2007","unstructured":"Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute Liver Failure. Am J Gastroenterol. 2007;102(11):2459\u201363.","journal-title":"Am J Gastroenterol"},{"key":"2180_CR8","first-page":"6","volume":"48","author":"Ordre des pharmaciens","year":"2015","unstructured":"Ordre des pharmaciens. La Su\u00e8de retire les comprim\u00e9s de parac\u00e9tamol des supermarch\u00e9s. Le J De l\u2019Ordre Natl Des Pharmaciens. 2015;48:6. 2015;48.","journal-title":"Le J De l\u2019Ordre Natl Des Pharmaciens"},{"key":"2180_CR9","unstructured":"ANSM. Actualit\u00e9 - Parac\u00e9tamol et risque pour le foie: un message d\u2019alerte ajout\u00e9 sur les bo\u00eetes de m\u00e9dicament - Communiqu\u00e9 - ANSM. https:\/\/ansm.sante.fr\/actualites\/paracetamol-et-risque-pour-le-foie-un-message-dalerte-ajoute-sur-les-boites-de-medicament-communique. Accessed 14 feb 2023."},{"key":"2180_CR10","unstructured":"ANSM. Actualit\u00e9 - Bon usage du parac\u00e9tamol et des anti-inflammatoires non st\u00e9ro\u00efdiens (AINS): ces m\u00e9dicaments ne pourront plus \u00eatre pr\u00e9sent\u00e9s en libre acc\u00e8s - ANSM. https:\/\/ansm.sante.fr\/actualites\/bon-usage-du-paracetamol-et-des-anti-inflammatoires-non-steroidiens-ains-ces-medicaments-ne-pourront-plus-etre-presentes-en-libre-acces. Accessed 14 feb 2023."},{"issue":"4","key":"2180_CR11","first-page":"17","volume":"31","author":"X Humbert","year":"2019","unstructured":"Humbert X, Jacquot J, Alexandre J, Sassier M, Robin N, Pageot C, et al. Informativit\u00e9 des d\u00e9clarations de pharmacovigilance en m\u00e9decine g\u00e9n\u00e9rale en France. Sante Publique (Bucur). 2019;31(4):17.","journal-title":"Sante Publique (Bucur)"},{"key":"2180_CR12","unstructured":"Chapman J, Arnold JK. Reye, syndrome. StatPearls Publishing; 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526101\/. Accessed 18 May 2022."},{"key":"2180_CR13","unstructured":"ANSM. Rapport-pv-ains-tours-marseille-2019.pdf. https:\/\/ansm.sante.fr\/uploads\/2020\/10\/29\/rapport-pv-ains-tours-marseille-2019.pdf. Accessed 18 May 2022."},{"issue":"645","key":"2180_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.53738\/REVMED.2019.15.645.0743","volume":"15","author":"F Rodieux","year":"2019","unstructured":"Rodieux F, Ing Lorenzini K, Rollason V. Importance et particularit\u00e9s de la pharmacovigilance en p\u00e9diatrie. Rev M\u00e9dicale Suisse. 2019;15(645):743.","journal-title":"Rev M\u00e9dicale Suisse"},{"issue":"5","key":"2180_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.therap.2016.04.001","volume":"71","author":"C Saint-Martin","year":"2016","unstructured":"Saint-Martin C, Kanagaratnam L, de Boissieu P, Azzouz B, Abou Taam M, Trenque T. Les effets ind\u00e9sirables m\u00e9dicamenteux en p\u00e9diatrie: exp\u00e9rience d\u2019un centre r\u00e9gional de pharmacovigilance. Therapies. 2016;71(5):467\u201373.","journal-title":"Therapies"},{"key":"2180_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12995-015-0084-3","volume":"10","author":"ME Mund","year":"2015","unstructured":"Mund ME, Quarcoo D, Gyo C, Br\u00fcggmann D, Groneberg DA. Paracetamol as a toxic substance for children: aspects of legislation in selected countries. J Occup Med Toxicol Lond Engl. 2015;10:43.","journal-title":"J Occup Med Toxicol Lond Engl"},{"key":"2180_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13052-023-01427-6","volume":"49","author":"M Marano","year":"2023","unstructured":"Marano M, Roversi M, Severini F, Memoli C, Musolino A, Pisani M, et al. Adverse Drugs reactions to Paracetamol and Ibuprofen in children: a 5-year report from a pediatric Poison control center in Italy. Ital J Pediatr. 2023;49:20.","journal-title":"Ital J Pediatr"},{"issue":"3","key":"2180_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11096-014-9933-x","volume":"36","author":"SS Allemann","year":"2014","unstructured":"Allemann SS, van Mil JWF, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical Care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544\u201355.","journal-title":"Int J Clin Pharm"},{"key":"2180_CR19","unstructured":"Code de la Sant\u00e9 Publique. Article R4235-48 - Code de la sant\u00e9 publique - L\u00e9gifrance. https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000006913703. Accessed 18 May 2022."},{"key":"2180_CR20","unstructured":"Code de la Sant\u00e9 Publique. Arr\u00eat\u00e9 du 28 novembre 2016 relatif aux bonnes pratiques de dispensation des m\u00e9dicaments dans les pharmacies d\u2019officine, les pharmacies mutualistes et les pharmacies de secours mini\u00e8res, mentionn\u00e9es \u00e0 l\u2019article L. 5121-5 du code de la sant\u00e9 publique - L\u00e9gifrance. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000033507633\/. Accessed 8 Mar 2022."},{"key":"2180_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/jppr200030110","volume":"30","author":"JM Bright","year":"2000","unstructured":"Bright JM, Tenni PC. The clinical servies documentation (CSD) system for documenting clinical pharmacist\u2019s services. Aust J Hosp Pharm. 2000;30:10\u20135.","journal-title":"Aust J Hosp Pharm"},{"issue":"3","key":"2180_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/archdischild-2012-302817","volume":"98","author":"B Maat","year":"2013","unstructured":"Maat B, Au YS, Bollen CW, van Vught AJ, Egberts TCG, Rademaker CMA. Clinical pharmacy interventions in paediatric electronic prescriptions. Arch Dis Child. 2013;98(3):222\u20137.","journal-title":"Arch Dis Child"},{"issue":"e1","key":"2180_CR23","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1136\/ejhpharm-2020-002319","volume":"28","author":"S Robert","year":"2021","unstructured":"Robert S, M\u00e9n\u00e9tr\u00e9 S, Schweitzer C, Demor\u00e9 B. Observational study of drug-related problems and clinical pharmacists\u2019 interventions in a French paediatric hospital. Eur J Hosp Pharm. 2021;28(e1):e85\u201391.","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"2180_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11096-012-9740-1","volume":"35","author":"S Prot-Labarthe","year":"2013","unstructured":"Prot-Labarthe S, Di Paolo ER, Lavoie A, Quennery S, Bussi\u00e8res JF, Brion F, et al. Pediatric drug-related problems: a multicenter study in four french-speaking countries. Int J Clin Pharm. 2013;35(2):251\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"2180_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.pharma.2018.12.002","volume":"77","author":"C Savanovitch","year":"2019","unstructured":"Savanovitch C, Prunet-Spano C, Davoust N, Werhl\u00e9 C, Amouroux F, Gourou A, et al. IPADAM Pharmaceutical interventions on the issue of pharmaceutical records and self-medication quanti survey in 482 French pharmacies. Ann Pharm Fr. 2019;77(3):198\u2013204.","journal-title":"Ann Pharm Fr"},{"issue":"3","key":"2180_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/pds.2241","volume":"21","author":"C Eickhoff","year":"2012","unstructured":"Eickhoff C, H\u00e4mmerlein A, Griese N, Schulz M. Nature and frequency of drug-related problems in self-medication (over-the-counter Drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf. 2012;21(3):254\u201360.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2180_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12889-019-6470-5","volume":"19","author":"S Tesfamariam","year":"2019","unstructured":"Tesfamariam S, Anand IS, Kaleab G, Berhane S, Woldai B, Habte E, et al. Self-medication with over the counter Drugs, prevalence of risky practice and its associated factors in pharmacy outlets of Asmara, Eritrea. BMC Public Health. 2019;19:159.","journal-title":"BMC Public Health"},{"issue":"2","key":"2180_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s11096-020-00984-8","volume":"42","author":"H Yl\u00e4-Rautio","year":"2020","unstructured":"Yl\u00e4-Rautio H, Siissalo S, Leikola S. Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications. Int J Clin Pharm. 2020;42(2):786\u201395.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"2180_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/15360288.2015.1082007","volume":"29","author":"C Gr\u00e9zy-Chabard\u00e8s","year":"2015","unstructured":"Gr\u00e9zy-Chabard\u00e8s C, Fournier JP, Dupouy J, Poutrain JC, Oustric S. Patients\u2019 knowledge about analgesic-antipyretic medications purchased in Community pharmacies: a descriptive study. J Pain Palliat Care Pharmacother. 2015;29(4):334\u201340.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"2180_CR30","first-page":"287","volume":"71","author":"AE Severin","year":"2016","unstructured":"Severin AE, Petitpain N, Scala-Bertola J, Latarche C, Yelehe-Okouma M, Di Patrizio P, et al. \u00c9tude prospective en pharmacie du bon usage et de la connaissance du parac\u00e9tamol pris en autom\u00e9dication. Ther juin. 2016;71(3):287\u201396.","journal-title":"Ther juin"},{"issue":"1","key":"2180_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1185\/03007995.2011.633990","volume":"28","author":"SL Michels","year":"2012","unstructured":"Michels SL, Collins J, Reynolds MW, Abramsky S, Paredes-Diaz A, McCarberg B. Over-the-counter ibuprofen and risk of gastrointestinal bleeding Complications: a systematic literature review. Curr Med Res Opin. 2012;28(1):89\u201399.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2180_CR32","first-page":"312","volume":"56","author":"P Tarciuc","year":"2020","unstructured":"Tarciuc P, Stanescu AMA, Diaconu CC, Paduraru L, Duduciuc A, Diaconescu S. Patterns and Factors Associated with Self-Medication among the Pediatric Population in Romania. Med (Mex). 2020;56(6):312.","journal-title":"Med (Mex)"},{"key":"2180_CR33","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - TOPLEXIL 0,33\u00a0mg\/ml SANS SUCRE, solution buvable \u00e9dulcor\u00e9e \u00e0 l\u2019ac\u00e9sulfame potassique - Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=68672780&typedoc=R. Accessed 28 Mar 2022."},{"issue":"4","key":"2180_CR34","first-page":"30","volume":"32","author":"C Scherpereel","year":"2020","unstructured":"Scherpereel C, Willeman T, Eysseric H, Allibe N, Scolan V, Fouilh\u00e9 N. Oxom\u00e9mazine Chez les moins de deux ans: \u00e0 propos D\u2019un cas de mort inattendue du nourrisson. Toxicol Anal Clin. 2020;32(4):30\u20131.","journal-title":"Toxicol Anal Clin"},{"key":"2180_CR35","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - VICKS VAPORUB, pommade - Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=64072763&typedoc=R. Accessed 28 Mar 2022."},{"key":"2180_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.anpedi.2016.06.002","volume":"86","author":"M Valenzuela Ortiz","year":"2017","unstructured":"Valenzuela Ortiz M, S\u00e1nchez Ruiz Cabello FJ, Uberos J, ChecaRos AF, Valenzuela Ortiz C, August\u00edn Morales MC, et al. Automedicaci\u00f3n, autoprescripci\u00f3n y medicaci\u00f3n \u00abpor poderes\u00bb en pediatr\u00eda. An Pediatr (Barc). 2017;86:264\u20139.","journal-title":"An Pediatr (Barc)"},{"key":"2180_CR37","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. Fiche info - TIORFAN 30\u00a0mg ENFANTS, poudre orale en sachet-dose - Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/extrait.php?specid=69778288. Accessed 20 Feb 2023."},{"key":"2180_CR38","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. Fiche info - VOGALIB 7,5\u00a0mg SANS SUCRE, lyophilisat oral \u00e9dulcor\u00e9 \u00e0 l\u2019aspartam - Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/extrait.php?specid=61183089. Accessed 20 Feb 2023."},{"issue":"11","key":"2180_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1345\/aph.1A065","volume":"35","author":"LT Westerlund","year":"2001","unstructured":"Westerlund LT, Marklund BR, Handl WH, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother. 2001;35(11):1343\u20139.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"2180_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.japh.2016.08.019","volume":"57","author":"O Abraham","year":"2017","unstructured":"Abraham O, Brothers A, Alexander DS, Carpenter DM. Pediatric medication use experiences and patient counseling in community pharmacies: perspectives of children and parents. J Am Pharm Assoc. 2017;57(1):38\u201346e2.","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"2180_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jadohealth.2012.06.027","volume":"51","author":"AD Bertoldi","year":"2012","unstructured":"Bertoldi AD, Telis Silveira MP, Menezes AMB, Formoso Assun\u00e7\u00e3o MC, Gon\u00e7alves H, Hallal PC. Tracking of Medicine Use and Self-Medication from Infancy to Adolescence: 1993 Pelotas (Brazil) Birth Cohort Study. J Adolesc Health. 2012;51(6):11\u20135.","journal-title":"J Adolesc Health"},{"issue":"2","key":"2180_CR42","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1542\/peds.2013-1107","volume":"133","author":"JF Jensen","year":"2014","unstructured":"Jensen JF, Gottschau M, Siersma VD, Graungaard AH, Holstein BE, Knudsen LE. Association of maternal self-medication and over-the-counter analgesics for children. Pediatrics. 2014;133(2):e291\u20138.","journal-title":"Pediatrics"},{"issue":"3","key":"2180_CR43","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/eurpub\/cku207","volume":"25","author":"MR Gualano","year":"2015","unstructured":"Gualano MR, Bert F, Passi S, Stillo M, Galis V, Manzoli L, et al. Use of self-medication among adolescents: a systematic review and meta-analysis. Eur J Public Health. 2015;25(3):444\u201350.","journal-title":"Eur J Public Health"},{"issue":"11","key":"2180_CR44","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/pds.3829","volume":"24","author":"S Italia","year":"2015","unstructured":"Italia S, Brand H, Heinrich J, Berdel D, von Berg A, Wolfenstetter SB. Utilization of self-medication and prescription Drugs among 15-year-old children from the German GINIplus birth cohort. Pharmacoepidemiol Drug Saf. 2015;24(11):1133\u201343.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2180_CR45","first-page":"182","volume":"91","author":"V De Sanctis","year":"2020","unstructured":"De Sanctis V, Soliman AT, Daar S, Di Maio S, Elalaily R, Fiscina B, et al. Prevalence, attitude and practice of self-medication among adolescents and the paradigm of dysmenorrhea self-care management in different countries. Acta Bio Medica Atenei Parm. 2020;91(1):182\u201392.","journal-title":"Acta Bio Medica Atenei Parm"},{"issue":"5","key":"2180_CR46","first-page":"1057","volume":"67","author":"C Pilorge","year":"2016","unstructured":"Pilorge C. Monopole Officinal et concurrence en prix pour la d\u00e9livrance des m\u00e9dicaments non remboursables: l\u2019exemple fran\u00e7ais. Rev Econ. 2016;67(5):1057\u201384.","journal-title":"Rev Econ"},{"key":"2180_CR47","unstructured":"Code de la sant\u00e9 publique -. Articles L4211-1 \u00e0 L4211-11 - Chapitre Ier: Dispositions g\u00e9n\u00e9rales. https:\/\/www.legifrance.gouv.fr\/codes\/section_lc\/LEGITEXT000006072665\/LEGISCTA000006171291\/#LEGISCTA000006171291. Accessed 20 Feb 2023."},{"key":"2180_CR48","unstructured":"Autorit\u00e9 de la concurrence. Avis 13-A-24 du 19 d\u00e9cembre 2013. Autorit\u00e9 de la concurrence. 2013. https:\/\/www.autoritedelaconcurrence.fr\/fr\/avis\/relatif-au-fonctionnement-de-la-concurrence-dans-le-secteur-de-la-distribution-du-medicament. Accessed 20 Feb 2023."},{"key":"2180_CR49","unstructured":"Code de la sant\u00e9 publique - JORF. n\u00b0 0072 du 24 mars 2020 - Arr\u00eat\u00e9 du 23 mars 2020 prescrivant les mesures d\u2019organisation et de fonctionnement du syst\u00e8me de sant\u00e9 n\u00e9cessaires pour faire face \u00e0 l\u2019\u00e9pid\u00e9mie de covid-19 dans le cadre de l\u2019\u00e9tat d\u2019urgence sanitaire. https:\/\/www.legifrance.gouv.fr\/jorf\/jo\/2020\/03\/24\/0072. Accessed 20 Feb 2023."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02180-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-023-02180-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02180-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T09:02:54Z","timestamp":1699261374000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-023-02180-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1186\/s12875-023-02180-9","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"27 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was registered with the French Commission on Information Technology, the Commission Nationale Informatique et Libert\u00e9s (n\u00b02016-13). According to french law (Decree No. 2017\u2009\u2212\u2009884 of May 9, 2017, Art. R. 1121-1.- I.), a positive Consultative Ethics Opinion was obtained from the Committee for the protection of persons South Est VI, Clermont-Ferrand (n\u00b0 2016\/CE17), which waived the need of informed consent. The study focuses on the professional practices of pharmacists who reported data collected in the context of their professional practice. In no case was a child questioned. This research have been performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"232"}}